Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaxil Bio Ltd (VXL.VN)

Vaxil Bio Ltd (VXL.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 11,613
  • Shares Outstanding, K 136,629
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,358 K
  • 60-Month Beta -3.70
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.88
Trade VXL.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings 0.00 on 03/31/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.080 +6.25%
on 07/30/21
0.095 -10.53%
on 07/13/21
unch (unch)
since 06/30/21
3-Month
0.080 +6.25%
on 07/30/21
0.120 -29.17%
on 05/05/21
-0.035 (-29.17%)
since 04/30/21
52-Week
0.075 +13.33%
on 11/09/20
0.770 -88.96%
on 01/04/21
-0.015 (-15.00%)
since 07/30/20

Most Recent Stories

More News
Vaxil Provides Research and Development Update

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil Announces CEO Resignation

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil Announces 2021 Reseach and Development Strategy and Progress

VAXIL BIO LTD. ("Vaxil" or the "Company") (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, today announces the direction and progress of its...

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil Provides Strategy Update From Conclusion of COVID-19 Challenge Study

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil Appoints a Special Advisor to the Board of Directors

FURTHER UPDATE ON USAMRIID CHALLENGE AND ADDITIONAL EUROPEAN PATENT GRANTED FOR VAXIL'S ANTICANCER ANTIBODY PLATFORM

VXL.VN : 0.085 (unch)
Vaxil Provides Update on USAMRIID, Oral Experiment and Other General Business Matters

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil's Annual and Special Shareholders Meeting and Update on Exercise of Warrants

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
VAXIL Provides Update on USAMRIID and Oral Experiments

VAXIL BIO LTD. ("Vaxil" or the "Company") (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, is pleased to announce that further to our press...

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil Retains Investor Engagement and Marketing Firm

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)
Vaxil Announces Close of Second and Final Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $264,100

Not for distribution by US newswire or in United States

VXLLF : 0.0750 (unch)
VXL.VN : 0.085 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.092
2nd Resistance Point 0.088
1st Resistance Point 0.087
Last Price 0.085
1st Support Level 0.082
2nd Support Level 0.078
3rd Support Level 0.077

See More

52-Week High 0.770
Fibonacci 61.8% 0.505
Fibonacci 50% 0.422
Fibonacci 38.2% 0.340
Last Price 0.085
52-Week Low 0.075

See More

Business Summary

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on its novel approach to targeting prominent cancer markers and infectious diseases. Its lead product ImMucin successfully completed a Phase 1/2 clinical trial in multiple myeloma for which it received orphan drug status from the FDA and...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar